Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion
Reuters reports that the Australian company's agreement to acquire ITM Isotope Technologies Munich SE is on a cash- and debt-free basis.
TLDR
Australia's Telix Pharmaceuticals said it has agreed to acquire Germany-based ITM Isotope Technologies Munich SE for about $1.65 billion on a cash- and debt-free basis, Reuters reports.
Combined views
95.3K
2 Sources, first seen ago